Mid-term outcomes of bioresorbable vascular scaffolds vs second-generation drug-eluting stents in patients with acute coronary syndromes: A systematic review and meta-analysis

BACKGROUND: Everolimus-eluting bioresorbable vascular scaffolds (BVS), which have the characteristics of scaffold absorption and vascular function recovery, are the latest innovation in the treatment of coronary artery disease. This new concept has become a hot topic in the field of interventional c...

Descripción completa

Detalles Bibliográficos
Autores principales: Ke, Junsong, Zhang, Hongyu, Huang, Jun, Lv, Ping, Yan, Jumei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478480/
https://www.ncbi.nlm.nih.gov/pubmed/32150103
http://dx.doi.org/10.1097/MD.0000000000019458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478480/
https://www.ncbi.nlm.nih.gov/pubmed/32150103
http://dx.doi.org/10.1097/MD.0000000000019458

Ejemplares similares